Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Fluorescence navigation is a novel technique for accurately identifying hepatocellular carcinoma (HCC) lesions during hepatectomy, enabling real-time visualization. Indocyanine green-based ...

Life-saving surgeries occur almost every day at NYU Langone Long Island, but one on Jan. 6 was unusual. Not only was Robert ...

A retrospective study including patients with advanced hepatocellular carcinoma (HCC) who received first-line atezolizumab plus bevacizumab (ate + bev) at 4 centers in Taiwan showed promising ...

This Series explores three key areas in the modern management of hepatocellular carcinoma. The first paper examines the personalisation of surgery for patients with hepatocellular carcinoma, which ...

Out of the 16 patients in the study, half had a strong response to the vaccine. A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a ...

Hepatocellular carcinoma (HCC), the most common type of liver tumor, is a leading cause of cancer-related deaths, and the incidence of liver cancer is still increasing worldwide. Curative hepatectomy ...

1Division of Life Sciences and Medicine, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, ...